These are glimpses into the work we do, the things we care about, and the milestones we’re working towards.

Five Things to Know About Hidradenitis Suppurativa

June 5 through 11 marks Hidradenitis Suppurativa (HS) Awareness Week in many countries around the world yet many may not have heard of this chronic and painful skin condition.

For Parkinson’s Patients, A Move From Measurement to Management

The progressive nature of Parkinson’s complicates how patients are treated – but a new tool strives to simplify.

Inside AbbVie’s Cambridge Research Center

One year later, research at our new neuroscience discovery center is in full swing.

Five Important Facts About Glioblastoma You Should Know

Learn about a particularly aggressive brain tumor called glioblastoma.

Unpeeling the Layers of Our Impact

Through our 2017 Impact by the Numbers, we’re exploring the true meaning of the phrase “remarkable impact."

Can Hepatitis C Be Eliminated by 2030? On the Path to Zero

AbbVie’s broad commitment to a global effort to cure hepatitis C (HCV) led to a policy, advocacy and awareness initiative called Path to Zero: Fresh Thinking on the Road to Eliminating HCV.

Eyeforpharma Awards AbbVie with 2017 “Most Valuable Patient Initiative" and “Most Valuable Pharma Collaboration”

Led by AbbVie Israel, more than 300 health care stakeholders across the country collaborated to build the awarded project, YouTube’s “Doctor’s Channel.”

Pushing Onward to Fight Neglected Diseases

Five years after the London Declaration, we can celebrate what we’ve accomplished. But we can’t forget how much still needs to be done.

Marking the Route to Sustainable Health Care

The first step was creating a roadmap for a more sustainable health care system. Now, it’s time to make that map digital.

Shining a Light on a Rare Blood Cancer

Every three minutes someone in the United States is diagnosed with blood cancer – and around half of those cancers are lymphoma. Learn key facts on symptoms, diagnosis and prevalence of Marginal Zone Lymphoma (MZL).